Tezampanel

DRUG2 trials

Sponsors

TorreyPines Therapeutics, Proniras Corporation

Conditions

MigraineOpioid Use Disorder

Phase 1

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

RecruitingNCT06538558

Proniras CorporationOpioid Use Disorder

Start: 2024-10-16End: 2027-11-30Target: 40Updated: 2026-09-17

Phase 2

Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine

CompletedNCT00567086

TorreyPines TherapeuticsMigraine

Start: 2006-10-31End: 2007-08-31Updated: 2007-12-04